QQQ   440.36 (+0.31%)
AAPL   179.58 (-0.65%)
MSFT   412.46 (-0.29%)
META   500.00 (+2.01%)
GOOGL   138.00 (-0.33%)
AMZN   176.74 (-0.01%)
TSLA   199.48 (-1.19%)
NVDA   801.76 (+1.34%)
NIO   5.71 (-0.70%)
AMD   195.87 (+1.73%)
BABA   74.82 (+1.07%)
T   16.95 (+0.12%)
F   12.48 (+0.32%)
MU   93.72 (+3.43%)
CGC   3.22 (-2.13%)
GE   158.22 (+0.85%)
DIS   111.40 (-0.16%)
AMC   4.34 (+0.46%)
PFE   26.69 (+0.49%)
PYPL   60.57 (+0.38%)
XOM   106.09 (+1.50%)
QQQ   440.36 (+0.31%)
AAPL   179.58 (-0.65%)
MSFT   412.46 (-0.29%)
META   500.00 (+2.01%)
GOOGL   138.00 (-0.33%)
AMZN   176.74 (-0.01%)
TSLA   199.48 (-1.19%)
NVDA   801.76 (+1.34%)
NIO   5.71 (-0.70%)
AMD   195.87 (+1.73%)
BABA   74.82 (+1.07%)
T   16.95 (+0.12%)
F   12.48 (+0.32%)
MU   93.72 (+3.43%)
CGC   3.22 (-2.13%)
GE   158.22 (+0.85%)
DIS   111.40 (-0.16%)
AMC   4.34 (+0.46%)
PFE   26.69 (+0.49%)
PYPL   60.57 (+0.38%)
XOM   106.09 (+1.50%)
QQQ   440.36 (+0.31%)
AAPL   179.58 (-0.65%)
MSFT   412.46 (-0.29%)
META   500.00 (+2.01%)
GOOGL   138.00 (-0.33%)
AMZN   176.74 (-0.01%)
TSLA   199.48 (-1.19%)
NVDA   801.76 (+1.34%)
NIO   5.71 (-0.70%)
AMD   195.87 (+1.73%)
BABA   74.82 (+1.07%)
T   16.95 (+0.12%)
F   12.48 (+0.32%)
MU   93.72 (+3.43%)
CGC   3.22 (-2.13%)
GE   158.22 (+0.85%)
DIS   111.40 (-0.16%)
AMC   4.34 (+0.46%)
PFE   26.69 (+0.49%)
PYPL   60.57 (+0.38%)
XOM   106.09 (+1.50%)
QQQ   440.36 (+0.31%)
AAPL   179.58 (-0.65%)
MSFT   412.46 (-0.29%)
META   500.00 (+2.01%)
GOOGL   138.00 (-0.33%)
AMZN   176.74 (-0.01%)
TSLA   199.48 (-1.19%)
NVDA   801.76 (+1.34%)
NIO   5.71 (-0.70%)
AMD   195.87 (+1.73%)
BABA   74.82 (+1.07%)
T   16.95 (+0.12%)
F   12.48 (+0.32%)
MU   93.72 (+3.43%)
CGC   3.22 (-2.13%)
GE   158.22 (+0.85%)
DIS   111.40 (-0.16%)
AMC   4.34 (+0.46%)
PFE   26.69 (+0.49%)
PYPL   60.57 (+0.38%)
XOM   106.09 (+1.50%)

Evolent Health (EVH) Stock Forecast & Price Target

$34.11
+0.20 (+0.59%)
(As of 09:58 AM ET)

Evolent Health Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 11 Analyst Ratings

Analysts' Consensus Price Target

$41.78
22.48% Upside
High Forecast$47.00
Average Forecast$41.78
Low Forecast$34.00
TypeCurrent Forecast
3/2/23 to 3/1/24
1 Month Ago
1/31/23 to 1/31/24
3 Months Ago
12/2/22 to 12/2/23
1 Year Ago
3/2/22 to 3/2/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
10 Buy rating(s)
8 Buy rating(s)
6 Buy rating(s)
8 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$41.78$41.25$45.50$47.67
Predicted Upside22.48% Upside38.07% Upside52.60% Upside57.08% Upside
Get Evolent Health Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.


EVH Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EVH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Evolent Health Stock vs. The Competition

TypeEvolent HealthComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.90
2.57
2.48
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside22.01% Upside202.60% Upside7.22% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/1/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$45.00+32.70%
2/23/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Outperform ➝ Market Outperform$37.00 ➝ $38.00+15.01%
2/23/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$47.00 ➝ $45.00+39.32%
1/9/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform
1/3/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$39.00+17.21%
11/28/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$44.00 ➝ $42.00+43.74%
11/16/2023Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform
11/14/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$36.00 ➝ $34.00+15.72%
10/16/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$46.00+64.29%
8/14/2023Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$47.00+65.03%
4/11/2023Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$40.00+24.80%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 08:31 AM ET.












EVH Price Target - Frequently Asked Questions

What is Evolent Health's consensus rating and price target?

According to the issued ratings of 11 analysts in the last year, the consensus rating for Evolent Health stock is Moderate Buy based on the current 1 hold rating and 10 buy ratings for EVH. The average twelve-month price prediction for Evolent Health is $41.78 with a high price target of $47.00 and a low price target of $34.00. Learn more on EVH's analyst rating history.

Do Wall Street analysts like Evolent Health more than its competitors?

Analysts like Evolent Health more than other Computer and Technology companies. The consensus rating score for Evolent Health is 2.91 while the average consensus rating score for computer and technology companies is 2.57. Learn more on how EVH compares to other companies.

Does Evolent Health's stock price have much upside?

According to analysts, Evolent Health's stock has a predicted upside of 34.45% based on their 12-month stock forecasts.

What analysts cover Evolent Health?

Evolent Health has been rated by Barclays, Canaccord Genuity Group, JMP Securities, Oppenheimer, and William Blair in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:EVH) was last updated on 3/1/2024 by MarketBeat.com Staff